Surmodics, Inc.
SRDX
|
$26.81
1.09%
4.7K
|
Health Technology
(0.0% 1d) (-4.6% 1m) (12.7% 1y) (0.0% 2d) (-0.3% 3d) (-1.8% 7d) (185.18% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 381,667,160
http://www.surmodics.com
Sec Filling | Patents | 370 employees
(US) SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
drug delivery diagnostics
add to watch list Paper trade email alert is off
Press-releases
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $39.49 0.66% 350K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
DHR | $237.72 -0.7% 1.4M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
BIO | $279.61 -3.87% 150K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
BDX | $231.62 -0.25% 130K
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.34%
A | $134.06 -0.36% 710K
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ABT | News | $105.52 -0.36% 1.6M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN | $39.49 0.66% 350K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN | $118.52 0.19% 530K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX | $74.97 0.07% 340K
|
Health Technology
|
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX | $0.7365 6.1K
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics market
Surmodics to Participate in Upcoming Investor Conferences in March and April
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: 1.24%
H: 0.54%
C: -0.39%
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Published: 2024-02-01 (Crawled : 14:00) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: -3.72%
H: 9.88%
C: -4.34%
first year financial
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Published: 2024-01-24 (Crawled : 22:00) - prnewswire.com
TRUMF | $17.112 1.5K
|
Health Technology
|
| O: 3.54%
H: 0.0%
C: 0.0%
TRUMY | $16.69 54K
|
Manufacturing
|
| O: -0.3%
H: 0.18%
C: -0.06%
PHG | News | $20.075 -0.37% 220K
|
Health Technology
|
| O: 0.0%
H: 0.57%
C: 0.48%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -1.0%
H: 0.84%
C: 0.04%
BSX | $67.96 1.3M
|
Health Technology
|
| O: 0.58%
H: 0.98%
C: 0.93%
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -1.34%
expected global growth market
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
Published: 2024-01-22 (Crawled : 13:30) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: -0.18%
H: 1.92%
C: -0.8%
removal
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
Published: 2024-01-16 (Crawled : 14:00) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: -1.3%
H: 1.02%
C: 0.63%
first report financial results
Surmodics to Host Virtual Annual Meeting of Shareholders - January 16, 2024
Published: 2024-01-16 (Crawled : 14:00) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: -1.3%
H: 1.02%
C: 0.63%
meeting
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2023-11-16 (Crawled : 15:30) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: 0.0%
H: 1.21%
C: 0.62%
trial
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: 4.02%
H: 2.91%
C: 2.91%
conference
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SRDX | $26.81 1.09% 4.7K
|
Health Technology
|
| O: 4.97%
H: 5.2%
C: 2.28%
year financial
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
HOLO | $2.86 27.68% 28M
|
XPON | $2.43 25.91% 7.2M
|
Last 48 Hours Insiders Buying
TPL P 3 | $591.39 1.1% 15K
|
Miscellaneous
|
15:00
RELL | $10.24 3.85% 36K
|
Electronic Technology
|
13:30
IZEA | $2.53 16K
|
Technology Services
|
00:00
RKT P 383 | $11.735 3.12% 640K
|
Finance
|
22:30
CTRN P 18090 | $23.035 2.97% 16K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% 44K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.07 -0.58% 840K
|
Health Technology
|
16:30
RMCF | $3.53 1.7K
|
Consumer Non-Durables
|
20:10